CLF: Shorts Retreat as Street Lifts Targets
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Cleveland-Cliffs heads into November with its post-earnings momentum intact, short sellers cutting exposure, and Citigroup the latest firm to chase targets higher, yet the consensus still barely clears the current price.
The positioning story has shifted meaningfully since the Q3 print. Short interest has fallen roughly 6.2% on the week to 11.8% of the free float, a notable pullback from the 80-million-share level that prevailed through most of October. That exit has come without any squeeze mechanics: borrow availability remains extremely loose at 820% of short interest, meaning there are more than eight shares available to lend for every one currently borrowed, the most room in the lending pool since early October. Cost to borrow has ticked up 24% on the week to 0.53%, but that remains a historically cheap rate for a name carrying this much short interest. The borrow market is telling a story of orderly short covering rather than a forced unwind. Options positioning has drifted slightly more defensive, with the put/call ratio at 0.54, about 1.5 standard deviations above its 20-day average of 0.50, though well within normal range and far from the 52-week high of 0.62 seen in late September.
The Street has been the more active story this week. Citigroup's Alexander Hacking lifted his target from $12 to $14 on October 30, keeping a Neutral rating, the most recent in a cluster of post-earnings revisions. JP Morgan moved to $13 from $12 on October 22, B. Riley raised to $18 from $15 maintaining Buy, and Morgan Stanley went to $14 from $12.50 at Equal-Weight. Barclays, which carries an Underweight, bumped its target a second time to $12. The result is a mean target of $14.05, barely above the October 30 close of $14.25. With the stock now marginally above the Street's central estimate, the consensus provides almost no cushion. The analyst recommendation divergence factor still ranks in the 94th percentile of the universe, a reflection of genuine conviction on both sides: Wells Fargo holds an Overweight at $17, Barclays sits at $12 Underweight, and most of the pack clusters at Neutral in between. EPS surprise ranks in the 75th percentile, consistent with a company that has repeatedly beaten estimates even as the fundamental debate persists. The EV/EBITDA multiple has compressed 1.8 turns over the past 30 days, while price-to-book has expanded roughly 0.19 turns in the same period, a pattern that fits a stock being re-rated on earnings momentum rather than improving fundamentals.
One genuine data point from the company's own regulatory footprint is worth noting. MSHA records show that safety violations issued at Cleveland-Cliffs mines ran 74% above Q2 last year, with 342 violations recorded through April 2026. The same period produced the smallest Q2 for employee hours worked at the company in five years, at 1.3 million hours. Neither dataset has been measured to lead the company's reported financial figures, so these are operational observations rather than forward signals. Separately, retail attention spiked sharply in early October, with the Wikipedia and ORTEX page-view z-score reaching 3.8 against the prior 90 days, consistent with the Q3 earnings announcement drawing fresh eyes to the name.
On the ownership side, the most interesting recent print is Slate Path Capital, which reported holding roughly 28.4 million shares as of June 30, a position that grew by 9.2 million shares in the period. PointState Capital and Avala Global both appear as new entrants in the same reporting window. BlackRock remains the largest disclosed holder at 9.8% of shares outstanding. No 13D activist filings are on the register; all large positions are disclosed as passive 13G holdings. The only open-market insider purchase in the past 90 days was director Edilson Camara's $100,000 buy at $13.49 on October 22, a modest signal but the only discretionary cash commitment from inside the company since the CFO's $2.9 million sale in June.
Among close peers, NUE gained 6.1% on the week and STLD rose 3.8%, while TX fell 5.7% and WS gave back 0.5%, so CLF's 2.5% weekly gain sits roughly in the middle of the peer range. The next earnings event is not until January 25, 2027, leaving 86 days for the debate between a $17 Overweight and a $12 Underweight to play out against whatever steel demand data arrives in the interim. The key watch is whether the short interest decline of the past week continues or stalls now that the stock has crossed back above the Street's mean target.
Stocks in this article
See the live data behind this article on ORTEX.
Open CLF on ORTEX →How this article was generated
- Generated
- 31 Oct 2026, 20:40
- Data as of
- 31 Oct 2026, 20:39
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.